Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
Infectious retrovirus particles consist of a core structure containing RNA and gag-pol polypeptides surrounded by a lipid membrane studded with env proteins. A recombinant vaccinia virus was designed to express the entire gag-pol precursor protein of the human immunodeficiency virus type 1. Synthesis and processing of gag proteins occurred in mammalian cells infected with this live recombinant virus, and reverse transcriptase was detected largely in the medium. Electron micrographs revealed immature retrovirus-like particles budding from the plasma membrane and extracellular particles with morphological characteristics of immature and mature human immunodeficiency virus. The latter contained functional reverse transcriptase as well as processed p24 and p17 gag polypeptides. Thus, assembly and maturation of human immunodeficiency virus-like particles can occur in the absence of either infectious RNA molecules or env proteins. The production of noninfectious virus-like particles by expression vectors should be useful for biochemical studies and could provide a safe source of material for the development of vaccines.
Karacostas
V
V
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.
Nagashima
K
K
Gonda
M A
MA
Moss
B
B
D000818:Animals; D002460:Cell Line; D015683:Gene Products, gag / Q000235:genetics / Q000302:isolation & purification; D005814:Genes, Viral; D005822:Genetic Vectors; D015497:HIV-1 / Q000235:genetics* / Q000648:ultrastructure; D008854:Microscopy, Electron; D010957:Plasmids; D012194:RNA-Directed DNA Polymerase / Q000235:genetics / Q000378:metabolism; D014616:Vaccinia virus / Q000235:genetics*; D015678:Viral Structural Proteins / Q000235:genetics
D015683:Gene Products, gag; D015678:Viral Structural Proteins; D012194:RNA-Directed DNA Polymerase